Patents by Inventor Catherine Eugenie Chaillan HUNTINGTON

Catherine Eugenie Chaillan HUNTINGTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC BINDING MOLECULES
    Publication number: 20240174758
    Abstract: The invention relates to binding molecules, such as antibodies, that bind to the chemokine receptor CCR9. More particularly, the invention relates to the treatment of CCR9-mediated diseases or conditions such as inflammatory bowel disease (IBD). and methods for the detection of CCR9, which make use of the binding molecules of the invention.
    Type: Application
    Filed: March 17, 2022
    Publication date: May 30, 2024
    Inventors: JOSQUIN ARNAUD NYS, ALBERT GEORGE THOM, PETER CARIUK, DARREN JONATHAN SCHOFIELD, AIDAN RILEY, CATHERINE EUGENIE CHAILLAN HUNTINGTON, DAVID GARETH REES, LORRAINE IRVING, MATTHEW ROBINSON
  • Dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of use thereof
    Patent number: 11904053
    Abstract: The present technology relates generally to dry powder formulations of antibodies specific for thymic stromal lymphopoietin (TSLP), as well as methods of treating asthma, using the dry powder formulations, suitably via pulmonary delivery.
    Type: Grant
    Filed: October 27, 2020
    Date of Patent: February 20, 2024
    Assignee: MEDIMMUNE LIMITED
    Inventors: Catherine Eugenie Chaillan Huntington, Susan Hoe, Prakash Manikwar, Roland Wilhelm Kolbeck, Emma Suzanne Cohen, David Lechuga-Ballesteros, Kellisa Beth Hansen, Dexter Joseph D'Sa, Saba Ghazvini
  • Dry Powder Formulations of Thymic Stromal Lymphopoietin (TSLP)-Binding Antibodies and Methods of Use Thereof
    Publication number: 20230201120
    Abstract: The present technology relates generally to dry powder formulations of antibodies specific for thymic stromal lymphopoietin (TSLP), as well as methods of treating asthma, using the dry powder formulations, suitably via pulmonary delivery.
    Type: Application
    Filed: November 9, 2022
    Publication date: June 29, 2023
    Inventors: Catherine Eugenie Chaillan Huntington, Susan Hoe, Prakash Manikwar, Roland Wilhelm Kolbeck, Emma Suzanne Cohen, David Lechuga-Ballesteros, Kellisa Beth Hansen, Dexter Joseph D'sa, Saba Ghazvini
  • DRY POWDER FORMULATIONS OF THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20210121406
    Abstract: The present technology relates generally to dry powder formulations of antibodies specific for thymic stromal lymphopoietin (TSLP), as well as methods of treating asthma, using the dry powder formulations, suitably via pulmonary delivery.
    Type: Application
    Filed: October 27, 2020
    Publication date: April 29, 2021
    Inventors: Catherine Eugenie Chaillan HUNTINGTON, Susan HOE, Prakash MANIKWAR, Roland Wilhelm KOLBECK, Emma Suzanne COHEN